News & Insights

Stay current
with Harbinger.

Press, perspectives, publications and more.

Harbinger Health Establishes RESOLVE™ as a New Category for Cancer Detection

Harbinger Health Establishes RESOLVE™ as a New Category for Cancer Detection Announces $100M financing to develop a portfolio of multi-cancer…

Featured News

Search

Filter by Category

PerspectivesPress ReleasesPublicationsOral PresentationsPapersPoster

Publications / Papers

Statistical methodology for MCED metrics

Publications / Poster

Analytical and Clinical Validation of a Methylation-Based cfDNA Assay for Early Detection of High-Mortality Cancers Using a Cost-Efficient Reflex Approach

Publications / Poster

Harbinger Health’s Technical Optimization and Assessment of xGen Hybridization and Wash v3 Kit Support Application for High-Throughput Targeted Methyl Sequencing

Publications / Poster

Validation of a Reflex cfDNA Methylation-based Multi-Cancer Early Detection (MCED) Blood Test in Individuals with Obesity

Publications / Poster

Blood-based MCED Testing During Routine Colonoscopies to Enhance Early Detection of High-Mortality Gastrointestinal Cancers

Publications / Poster

Validation of a Reflex cfDNA Methylation-based Multi-Cancer Early Detection (MCED) Blood Test for Tumors Lacking Routine Screening in Asymptomatic Adults

Publications / Poster

GEM: A deep generative framework for synthetic generation of plasma cfDNA methylation profiles

Publications / Poster

Using Cell Type Deconvolution to Add Immune, Metastatic, and Health Context toMethylation-based Early Cancer Detection